Call: 631.543.3334

Gemini Pharmaceuticals Inc. Names New Senior Vice President of Retail Sales

For Immediate Release

Media Contact: Mark Jost 631-543-3334

joni-smallCommack, NY, March 30, 2015 – Gemini Pharmaceuticals Inc., a global manufacturer of specialty pharmaceuticals, Over the Counter (OTC) pharmaceuticals, and dietary and nutritional supplements for the past 30 years, announces the appointment of Joni Foley as the new Senior Vice President of Retail Sales.

Joni has over 25 years of sales and marketing experience with more than 14 years concentrating on private brand offerings for retail firms. She was previously Senior Sales Director of PL Developments, located in Westbury, NY. During her career, Joni has worked with every major retail company in the US. She holds a BA in Creative Writing from New York University and a BS in Business Management from Adelphi University.

“We are very excited to have Joni as a member of our Gemini team. Her primary focus will be to expand our product distribution into the retail channel. In addition, she will develop the processes and recommend the staff needed to accommodate significant expansion of Gemini business in this market segment. Joni has established close relationships with many retail partners which resulted in significant growth for her former companies. Her many years of experience in the health, beauty and cosmetic space, and especially in private brands, will be a great asset to Gemini as we are committed to aggressively exceed our consistent year-over-year double-digit growth” offers Mike Finamore, CEO of Gemini Pharmaceuticals Inc.

About Gemini Pharmaceuticals Inc.:

Gemini Pharmaceuticals Inc. is a global manufacturer of specialty pharmaceuticals, Over the Counter (OTC) pharmaceuticals, and dietary and nutritional supplements. With over 30 years of experience, Gemini has grown to be a world class manufacturer of solid dosage product with production exceeding 18 billion tablets / capsules per year. The quality of the operation has been recognized by the achievement of both NSF and TGA registrations and the issuance of a Foreign Site Reference Number by Health Canada. Gemini also produces its products in compliance with both Kosher and Halal requirements. For additional information about Gemini Pharmaceuticals please see or contact Mark Jost at

Media Contact: Mark Jost, 631-543-3334;

Comments are closed.